PROLARYN PLUS INJECTABLE IMPLANT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2018-01-23 for PROLARYN PLUS INJECTABLE IMPLANT manufactured by Merz North America.

Event Text Entries

[98013913] The case was assessed as reportable to the fda. The device history record could not be reviewed as the lot number was not provided.
Patient Sequence No: 1, Text Type: N, H10


[98013914] This spontaneous report was received from a south african physician and concerns a patient. The patient was injected with prolaryn? Plus into the vocal cord. The surgeon may have over delivered prolaryn? Plus into a vocal cord and inquired recommendations regarding the procedure for surgical retrieval of the excess of product. Follow-up information was received on 15-jan-2018: the case was upgraded to serious. The events "foreign material with surrounding fibrosis" and "minimal foreign body granulomatous reaction" were added. Event term "delivered prolaryn? Plus into a vocal cord" was changed to "delivered prolaryn? Plus into a vocal cord/over injected/possibly overfull" and this event was considered serious. The case concerns a female patient. She was injected with prolaryn? Plus lateral to the vocal fold to improve voice. In the opinion of a surgeon, the product was incorrectly and over-injected, possibly overfull and a bit superficial. The patient's medical history included left vocal fold palsy. A few hours after the treatment with prolaryn? Plus, the patient had a reaction but went home the same day. At four months post injection, the second surgeon tried to resect prolaryn? Plus via a lateral (thyroidectomy) approach. He stated that the patient had fibrosis and her voice was always going to be hoarse. Therefore, the outcome of this event was deemed not recovered. The histology showed fragments of voluntary muscle with focuses of foreign material with surrounding fibrosis and minimal foreign body granulomatous reaction. That was summarized as voluntary muscle with focal deposits of partially calcified foreign material. In the opinion of the reporter, the event of "minimal foreign body granulomatous reaction" was of mild intensity.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2135225-2018-00001
MDR Report Key7213370
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2018-01-23
Date of Report2018-02-27
Date Mfgr Received2018-02-21
Date Added to Maude2018-01-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA3
Event Location3
Manufacturer ContactSCOTT SYKES, MD
Manufacturer Street6501 SIX FORKS ROAD
Manufacturer CityRALEIGH NC 27615
Manufacturer CountryUS
Manufacturer Postal27615
Manufacturer Phone9195828000
Manufacturer G1MERZ NORTH AMERICA, INC.
Manufacturer Street4133 COURTNEY STREET SUITE 10
Manufacturer CityFRANKSVILLE WI 53126
Manufacturer CountryUS
Manufacturer Postal Code53126
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePROLARYN PLUS INJECTABLE IMPLANT
Generic NamePOLYMER, ENT SYNTHETIC POLYAMIDE
Product CodeKHJ
Date Received2018-01-23
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerMERZ NORTH AMERICA
Manufacturer Address4133 COURTNEY STREET SUITE 10 FRANKSVILLE WI 53126 US 53126


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2018-01-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.